Business Standard

Moderna requests FDA to authorize second Covid-19 booster shot for adults

Moderna submitted a request to the US Food and Drug Administration (FDA) for emergency use authorization on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older

Moderna Covid-19 vaccine

ANI US
American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already received a booster dose of any approved or authorized shot.
The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to "determine the appropriate use of an additional booster dose," including for those at higher risk of COVID-19 due to age or comorbidities, said the company in a statement.
Currently, a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the United States for adults 18 years and older.
Moderna said it continues to collect and monitor real-world data on its COVID-19 vaccine. Clinical trials are ongoing for Moderna's Omicron-specific booster and a bivalent Omicron-specific booster.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 19 2022 | 7:33 AM IST

Explore News